Imaging glioblastoma posttreatment: progression, pseudoprogression, pseudoresponse, radiation necrosis

SB Strauss, A Meng, EJ Ebani… - Neuroimaging …, 2021 - neuroimaging.theclinics.com
Eighty percent of all malignant primary brain tumors diagnosed in the United States are
gliomas. 1 The current treatment paradigm for high-grade gliomas (grades III and IV) …

Circulating tumor DNA in Hodgkin lymphoma

M Maco, K Kupcova, V Herman, I Ondeckova… - Annals of …, 2022 - Springer
Somatic mutations of genes involved in NF-κB, PI3K/AKT, NOTCH, and JAK/STAT signaling
pathways play an important role in the pathogenesis of Hodgkin lymphoma (HL). HL tumor …

[HTML][HTML] Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion …

T Kazda, M Bulik, P Pospisil, R Lakomy, M Smrcka… - NeuroImage: Clinical, 2016 - Elsevier
The accurate identification of glioblastoma progression remains an unmet clinical need. The
aim of this prospective single-institutional study is to determine and validate thresholds for …

Five-year relative survival by stage of breast and colon cancers in northern Italy

L Mangone, F Marinelli, I Bisceglia… - Frontiers in …, 2022 - frontiersin.org
The aim of this study is to present the 5-year relative survival by stage of breast and
colorectal cancer patients in a northern Italian province. For the period 2013-2015, cases …

Demographic shift disproportionately increases cancer burden in an aging nation: current and expected incidence and mortality in Hungary up to 2030

O Menyhárt, JT Fekete, B Győrffy - Clinical Epidemiology, 2018 - Taylor & Francis
Background Population aging is a common demographic pattern in developed countries,
and aging increases the risk of cancer. The disproportionately high cancer burden, as a …

Serum levels of TIMP-1 and MMP-7 as potential biomarkers in patients with metastatic colorectal cancer

M Vočka, D Langer, V Fryba, J Petrtyl… - … journal of biological …, 2019 - journals.sagepub.com
Objective: Tissue inhibitor of metalloproteinases 1 (TIMP-1) and matrix metalloproteinase 7
(MMP-7) were reported to have potent growth promoting activity. Lack of balance between …

[HTML][HTML] Double-strand break repair and colorectal cancer: gene variants within 3′ UTRs and microRNAs binding as modulators of cancer risk and clinical outcome

A Naccarati, F Rosa, V Vymetalkova, E Barone… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Genetic variations in 3′ untranslated regions of target genes may affect microRNA binding,
resulting in differential protein expression. microRNAs regulate DNA repair, and single …

Novel serum markers HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer

M Vocka, D Langer, V Fryba, J Petrtyl… - Oncology …, 2019 - spandidos-publications.com
Colorectal cancer (CRC) is the second leading tumor diagnosis in women and men in the
Czech Republic. Patient outcome depends on tumor stage at the time of diagnosis and, in …

Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma

H Mlcochova, T Machackova, A Rabien, L Radova… - Scientific reports, 2016 - nature.com
Clear-cell renal cell carcinomas (ccRCCs) are genetically heterogeneous tumors presenting
diverse clinical courses. Epithelial-mesenchymal transition (EMT) is a crucial process …

[PDF][PDF] The impact of high protein nutritional support on clinical outcomes and treatment costs of patients with colorectal cancer

V Maňásek, K Bezděk, A Foltys, K Klos, J Smitka… - Klin Onkol, 2016 - linkos.cz
Background: The primary objective of this study was to investigate the impact of high protein
oral nutrition support (ONS) on clinical outcomes in patients with colorectal cancer (CRC) …